Health Care & Life Sciences » Biotechnology | Tiziana Life Sciences PLC

Tiziana Life Sciences PLC | Income Statement

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3.00
-
-
-
-
12
Cost of Goods Sold (COGS) incl. D&A
-
-
-
8.00
11.00
12
Gross Income
-
-
-
8.00
11.00
12
SG&A Expense
-
2,580.00
8,614.00
7,280.00
8,200.00
7,655
EBIT
265.00
-
8,614.00
7,288.00
8,211.00
7,667
Unusual Expense
18.00
793.00
-
-
-
-
Non Operating Income/Expense
-
-
-
-
35.00
222
Interest Expense
-
14.00
18.00
9.00
9.00
9
Pretax Income
283.00
3,387.00
8,632.00
7,297.00
8,255.00
7,454
Income Tax
-
60.00
-
89.00
1,485.00
1,459
Consolidated Net Income
283.00
3,327.00
8,632.00
7,208.00
6,770.00
5,995
Net Income
283.00
3,327.00
8,632.00
7,208.00
6,770.00
5,995
Net Income After Extraordinaries
283.00
3,327.00
8,632.00
7,208.00
6,770.00
5,995
Net Income Available to Common
283.00
3,327.00
8,632.00
7,208.00
6,770.00
5,995
EPS (Basic)
0.15
0.14
0.09
0.08
0.06
0.05
Basic Shares Outstanding
1,821.10
22,866.40
91,242.90
93,592.20
106,403.90
127,553.90
EPS (Diluted)
0.16
0.15
0.09
0.08
0.06
0.05
Diluted Shares Outstanding
1,821.10
22,866.40
91,242.90
93,592.20
106,403.90
127,553.90
EBITDA
265.00
2,580.00
8,614.00
7,280.00
8,200.00
7,655
Other Operating Expense
268.00
-
-
-
-
-

About Tiziana Life Sciences

View Profile
Address
55 Park Lane
London Greater London W1K 1NA
United Kingdom
Employees -
Website http://www.tizianalifesciences.com
Updated 07/08/2019
Tiziana Life Sciences Plc operates as a clinical stage biotechnology company that focuses on the discovery and development of drugs that treat human disease in oncology and immunology. The company was founded by Gabriele Marco Antonio Cerrone on November 4, 2013 and is headquartered in London, the United Kingdom. .

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.